Joellen Schildkraut, PhD, MPH

Research Program

Cancer Prevention and Control
Phone Number

404-727-3288
Email Address

joellen.m.schildkraut@emory.edu

Biography

Joellen M. Schildkraut, PhD, MPH, is a professor in the Department of Epidemiology at the Rollins School of Public Health. Dr. Schildkraut is a member of the Cancer Prevention and Control Research Program at Winship Cancer Institute of Emory University in Atlanta, Georgia.

Education

Dr. Schildkraut received both her MPH and PhD from Yale University. Her doctoral dissertation and early publications focused on the genetic overlap between breast and ovarian cancer through examination of family history. This work indirectly contributed to the discovery of BRCA1 and BRCA2, the two highly penetrant genes associated with increased risk of breast and ovarian cancers.

Titles & Roles

Professor, Department of Epidemiology

Rollins School of Public Health, Emory University

Research

Dr. Schildkraut has studied for much of her career the genetic epidemiology of ovarian, breast, and brain tumors, for which she has utilized innovative technologies and data science approaches to reconsider the biology and epidemiology of these diseases.

Grants

View Grants

Grant Number	Title
1R01CA237318-01A1	Ovarian Cancer Survival in African-American Women
1R01CA248288-01A1	Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk
5R01CA237318-02	Ovarian Cancer Survival in African-American Women
5R01CA237318-03	Ovarian Cancer Survival in African-American Women
5R01CA237318-04	Ovarian Cancer Survival in African-American Women
5R01CA237318-05	Ovarian Cancer Survival in African-American Women

Publications

Dr. Schildkraut has authored nearly 360 peer-reviewed journal articles and contributed book chapters to numerous textbooks including Approaches to Gene Mapping in Complex Human Diseases and Principles and Practice of Oncology. She has presented her research at major research conferences and spoken at events across the country.

Title/Journal	Authors	Publication Date
Mapping Inherited Genetic Variation with Opposite Effects on Autoimmune Disease and Four Cancer Types Identifies Candidate Drug Targets Associated with the Anti-Tumor Immune Response. Genes	J Chen, MP Epstein, JM Schildkraut, SP Kar	05/14/2025
Perceived discrimination, trust in physicians, and their associations with ovarian cancer mortality among women in the African American Cancer Epidemiology Study. Cancer causes & control : CCC	LJ Collin, CE Johnson, M Akonde, M Kan, EV Bandera, LC Peres, B Qin, ML Cote, A Alberg, ES Peters, TA Hastert, JM Schildkraut	05/06/2025
Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	LJ Collin, KL Cushing-Haugen, KL Terry, EL Goode, AH Wu, HR Harris, N Sasamoto, DW Cramer, F Modugno, E Elishaev, Z Fu, KB Moysich, PA Fasching, CL Pearce, U Menon, A Gentry-Maharaj, SA Gayther, N Wentzensen, MT Goodman, J George, A Talhouk, MS Anglesio, SJ Ramus, DDL Bowtell, SS Tworoger, JM Schildkraut, PM Webb, JA Doherty	05/02/2025
Genomic Characterization of High-Grade Serous Ovarian Carcinoma Reveals Distinct Somatic Features in Black Individuals. Cancer research	KA Lawson-Michod, JR Marks, LJ Collin, DA Nix, NR Davidson, CD Huff, Y Yu, A Atkinson, CE Johnson, LA Salas, LC Peres, CS Greene, JM Schildkraut, JA Doherty	05/02/2025
Childhood Household Dysfunction and Low Household Income Associate with Increased Risk of Cirrhosis in Adults. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association	KC Miller, A Parish, MA Troester, JM Schildkraut, C Hoyo, CA Moylan	04/09/2025
Cigarette smoking in relation to survival in Black women with ovarian cancer: Evidence from the African American Cancer Epidemiology Study (AACES). Annals of epidemiology	M Akonde, AJ Alberg, C Johnson, EV Bandera, LJ Collin, ML Cote, TA Hastert, LC Peres, ES Peters, B Qin, PD Terry, AB Lawson, JM Schildkraut	04/01/2025
Diet and survival after a diagnosis of ovarian cancer: a pooled analysis from the Ovarian Cancer Association Consortium. The American journal of clinical nutrition	CM Nagle, TI Ibiebele, R Na, EV Bandera, D Cramer, JA Doherty, GG Giles, MT Goodman, GE Hanley, HR Harris, A Jensen, SK Kjaer, A Lee, V McGuire, RL Milne, B Qin, J Richardson, N Sasamoto, JM Schildkraut, W Sieh, KL Terry, L Titus, B Trabert, N Wentzensen, AH Wu, A Berchuck, MC Pike, CL Pearce, PM Webb	04/01/2025
Homologous recombination deficiency in ovarian high-grade serous carcinoma by self-reported race. medRxiv : the preprint server for health sciences	KA Lawson-Michod, CE Johnson, ME Barnard, N Davidson, LJ Collin, DA Nix, C Huff, A Berchuck, LA Salas, C Greene, JR Marks, LC Peres, JA Doherty, JM Schildkraut	01/28/2025
Comorbid conditions and survival among Black women with ovarian cancer. Cancer	AR Richards, CE Johnson, NR Montalvo, AJ Alberg, EV Bandera, M Bondy, LJ Collin, ML Cote, TA Hastert, K Haller, N Khanna, JR Marks, ES Peters, B Qin, J Staples, PD Terry, A Lawson, JM Schildkraut, LC Peres	01/01/2025
The role of multiple mediation with contextual neighborhood measures in ovarian cancer survival. Annals of epidemiology	AB Lawson, Y Xin, ES Peters, C Johnson, T Hastert, EV Bandera, AJ Alberg, L Collin, P Terry, M Akonde, H Mandle, ML Cote, M Bondy, J Marks, LC Peres, KL Ratnapradipa, JM Schildkraut	11/01/2024
Diet and Survival in Black Women With Epithelial Ovarian Cancer. JAMA network open	TA Armidie, EV Bandera, CE Johnson, LC Peres, K Haller, P Terry, M Akonde, ES Peters, ML Cote, TA Hastert, LJ Collin, M Epstein, J Marks, M Bondy, AB Lawson, AJ Alberg, JM Schildkraut, B Qin	10/01/2024
Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium. American journal of epidemiology	NS Meagher, KK White, LR Wilkens, EV Bandera, A Berchuck, ME Carney, DW Cramer, KL Cushing-Haugen, S Jordan, SH Kaufmann, ND Le, MC Pike, M Riggan, B Qin, JH Rothstein, L Titus, SJ Winham, H Anton-Culver, JA Doherty, EL Goode, CL Pearce, HA Risch, PM Webb, LS Cook, MT Goodman, HR Harris, L Le Marchand, V McGuire, PDP Pharoah, D Sarink, JM Schildkraut, W Sieh, KL Terry, PJ Thompson, AS Whittemore, AH Wu, LC Peres, MA Merritt	09/03/2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research	FAM Saner, K Takahashi, T Budden, A Pandey, D Ariyaratne, TA Zwimpfer, NS Meagher, S Fereday, L Twomey, KI Pishas, T Hoang, A Bolithon, N Traficante, K Alsop, EL Christie, EY Kang, GS Nelson, P Ghatage, CH Lee, MJ Riggan, J Alsop, MW Beckmann, J Boros, AH Brand, A Brooks-Wilson, ME Carney, P Coulson, M Courtney-Brooks, KL Cushing-Haugen, C Cybulski, MA El-Bahrawy, E Elishaev, R Erber, SA Gayther, A Gentry-Maharaj, CB Gilks, PR Harnett, HR Harris, A Hartmann, A Hein, J Hendley, BY Hernandez, A Jakubowska, M Jimenez-Linan, ME Jones, SH Kaufmann, CJ Kennedy, T Kluz, JM Koziak, B Kristjansdottir, ND Le, M Lener, J Lester, J Lubiński, C Mateoiu, S Orsulic, M Ruebner, MJ Schoemaker, M Shah, R Sharma, ME Sherman, YB Shvetsov, TR Soong, H Steed, P Sukumvanich, A Talhouk, SE Taylor, RA Vierkant, C Wang, M Widschwendter, LR Wilkens, SJ Winham, MS Anglesio, A Berchuck, JD Brenton, I Campbell, LS Cook, JA Doherty, PA Fasching, RT Fortner, MT Goodman, J Gronwald, DG Huntsman, BY Karlan, LE Kelemen, U Menon, F Modugno, PDP Pharoah, JM Schildkraut, K Sundfeldt, AJ Swerdlow, EL Goode, A DeFazio, M Köbel, SJ Ramus, DDL Bowtell, DW Garsed	08/15/2024
Molecular Subtypes of High-Grade Serous Ovarian Cancer across Racial Groups and Gene Expression Platforms. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	NR Davidson, ME Barnard, AA Hippen, A Campbell, CE Johnson, GP Way, BK Dalley, A Berchuck, LA Salas, LC Peres, JR Marks, JM Schildkraut, CS Greene, JA Doherty	08/01/2024
Carcinogenicity of talc and acrylonitrile. The Lancet. Oncology	LT Stayner, T Carreón-Valencia, PA Demers, JM Fritz, MR Sim, P Stewart, H Tsuda, A Cardenas, D Consonni, L Davies, S De Matteis, E Felley-Bosco, AJ Ghio, T Göen, Y Grosse, AF Gualtieri, PD Josephy, S Koutros, I Linhart, H Louro, KM O'Brien, S Panzacchi, L Peña, P Rössner, JM Schildkraut, AB Stefaniak, N Wentzensen, P Wild, Y Xu, A de Conti, C Facchin, R Wedekind, A Ahmadi, J Blanco, S Chittiboyina, S Kulasingam, R MacLehose, M Motlhale, S Shah, E Suonio, H Mattock, A Kunzmann, F Madia, E Pasqual, L Benbrahim-Tallaa, MK Schubauer-Berigan	08/01/2024
Cis- and trans-eQTL TWASs of breast and ovarian cancer identify more than 100 susceptibility genes in the BCAC and OCAC consortia. American journal of human genetics	ST Head, F Dezem, A Todor, J Yang, J Plummer, S Gayther, S Kar, J Schildkraut, MP Epstein	06/06/2024
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions. American journal of human genetics	EO Dareng, SG Coetzee, JP Tyrer, PC Peng, W Rosenow, S Chen, BD Davis, FS Dezem, JH Seo, R Nameki, AL Reyes, KKH Aben, H Anton-Culver, NN Antonenkova, G Aravantinos, EV Bandera, LE Beane Freeman, MW Beckmann, A Beeghly-Fadiel, J Benitez, MQ Bernardini, L Bjorge, A Black, NV Bogdanova, KL Bolton, JD Brenton, A Budzilowska, R Butzow, H Cai, I Campbell, R Cannioto, J Chang-Claude, SJ Chanock, K Chen, G Chenevix-Trench, YE Chiew, LS Cook, A DeFazio, J Dennis, JA Doherty, T Dörk, A du Bois, M Dürst, DM Eccles, G Ene, PA Fasching, JM Flanagan, RT Fortner, F Fostira, A Gentry-Maharaj, GG Giles, MT Goodman, J Gronwald, CA Haiman, N Håkansson, F Heitz, MAT Hildebrandt, E Høgdall, CK Høgdall, RY Huang, A Jensen, ME Jones, D Kang, BY Karlan, AN Karnezis, LE Kelemen, CJ Kennedy, EK Khusnutdinova, LA Kiemeney, SK Kjaer, J Kupryjanczyk, M Labrie, D Lambrechts, MC Larson, ND Le, J Lester, L Li, J Lubiński, M Lush, JR Marks, K Matsuo, T May, JR McLaughlin, IA McNeish, U Menon, S Missmer, F Modugno, M Moffitt, AN Monteiro, KB Moysich, SA Narod, T Nguyen-Dumont, K Odunsi, H Olsson, NC Onland-Moret, SK Park, T Pejovic, JB Permuth, A Piskorz, D Prokofyeva, MJ Riggan, HA Risch, C Rodríguez-Antona, MA Rossing, DP Sandler, VW Setiawan, K Shan, H Song, MC Southey, H Steed, R Sutphen, AJ Swerdlow, SH Teo, KL Terry, PJ Thompson, LC Vestrheim Thomsen, L Titus, B Trabert, R Travis, SS Tworoger, E Valen, E Van Nieuwenhuysen, DV Edwards, RA Vierkant, PM Webb, CR Weinberg, RM Weise, N Wentzensen, E White, SJ Winham, A Wolk, YL Woo, AH Wu, L Yan, D Yannoukakos, N Zeinomar, W Zheng, A Ziogas, A Berchuck, EL Goode, DG Huntsman, CL Pearce, SJ Ramus, TA Sellers, ML Freedman, K Lawrenson, JM Schildkraut, D Hazelett, JT Plummer, S Kar, MR Jones, PDP Pharoah, SA Gayther	06/06/2024
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease. NPJ genomic medicine	D Ramachandran, JP Tyrer, S Kommoss, A DeFazio, MJ Riggan, PM Webb, PA Fasching, D Lambrechts, MJ García, C Rodríguez-Antona, MT Goodman, F Modugno, KB Moysich, BY Karlan, J Lester, SK Kjaer, A Jensen, E Høgdall, EL Goode, WA Cliby, A Kumar, C Wang, JM Cunningham, SJ Winham, AN Monteiro, JM Schildkraut, DW Cramer, KL Terry, L Titus, L Bjorge, LCV Thomsen, T Pejovic, CK Høgdall, IA McNeish, T May, DG Huntsman, J Pfisterer, U Canzler, TW Park-Simon, W Schröder, A Belau, L Hanker, P Harter, J Sehouli, R Kimmig, N de Gregorio, B Schmalfeldt, K Baumann, F Hilpert, A Burges, B Winterhoff, P Schürmann, LM Speith, P Hillemanns, A Berchuck, SE Johnatty, SJ Ramus, G Chenevix-Trench, PDP Pharoah, T Dörk, F Heitz	03/05/2024
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk. medRxiv : the preprint server for health sciences	DR Barnes, JP Tyrer, J Dennis, G Leslie, MK Bolla, M Lush, AM Aeilts, K Aittomäki, N Andrieu, IL Andrulis, H Anton-Culver, A Arason, BK Arun, J Balmaña, EV Bandera, RB Barkardottir, LPV Berger, AB de Gonzalez, P Berthet, K Białkowska, L Bjørge, AM Blanco, MJ Blok, KA Bobolis, NV Bogdanova, JD Brenton, H Butz, SS Buys, MA Caligo, I Campbell, C Castillo, KBM Claes, SV Colonna, LS Cook, MB Daly, A Dansonka-Mieszkowska, M de la Hoya, A deFazio, A DePersia, YC Ding, SM Domchek, T Dörk, Z Einbeigi, C Engel, DG Evans, L Foretova, RT Fortner, F Fostira, MC Foti, E Friedman, MN Frone, PA Ganz, A Gentry-Maharaj, G Glendon, AK Godwin, A González-Neira, MH Greene, J Gronwald, A Guerrieri-Gonzaga, U Hamann, TVO Hansen, HR Harris, J Hauke, F Heitz, FBL Hogervorst, MJ Hooning, JL Hopper, CD Huff, DG Huntsman, EN Imyanitov, L Izatt, A Jakubowska, PA James, R Janavicius, EM John, S Kar, BY Karlan, CJ Kennedy, LALM Kiemeney, I Konstantopoulou, J Kupryjanczyk, Y Laitman, O Lavie, K Lawrenson, J Lester, F Lesueur, C Lopez-Pleguezuelos, PL Mai, S Manoukian, T May, IA McNeish, U Menon, RL Milne, F Modugno, JM Mongiovi, M Montagna, KB Moysich, SL Neuhausen, FC Nielsen, C Noguès, E Oláh, OI Olopade, A Osorio, L Papi, H Pathak, CL Pearce, IS Pedersen, A Peixoto, T Pejovic, PC Peng, BN Peshkin, P Peterlongo, CB Powell, D Prokofyeva, MA Pujana, P Radice, MU Rashid, G Rennert, G Richenberg, DP Sandler, N Sasamoto, VW Setiawan, P Sharma, W Sieh, CF Singer, K Snape, AP Sokolenko, P Soucy, MC Southey, D Stoppa-Lyonnet, R Sutphen, C Sutter, MR Teixeira, KL Terry, LCV Thomsen, M Tischkowitz, AE Toland, T Van Gorp, A Vega, DR Velez Edwards, PM Webb, JN Weitzel, N Wentzensen, AS Whittemore, SJ Winham, AH Wu, S Yadav, Y Yu, A Ziogas, A Berchuck, FJ Couch, EL Goode, MT Goodman, AN Monteiro, K Offit, SJ Ramus, HA Risch, JM Schildkraut, M Thomassen, J Simard, DF Easton, MR Jones, G Chenevix-Trench, SA Gayther, AC Antoniou, PDP Pharoah	03/04/2024
Mapping inherited genetic variation with opposite effects on autoimmune disease and cancer identifies candidate drug targets associated with the anti-tumor immune response. medRxiv : the preprint server for health sciences	J Chen, MP Epstein, JM Schildkraut, SP Kar	12/28/2023
Molecular subtypes of high-grade serous ovarian cancer across racial groups and gene expression platforms. bioRxiv : the preprint server for biology	NR Davidson, ME Barnard, AA Hippen, A Campbell, CE Johnson, GP Way, BK Dalley, A Berchuck, LA Salas, LC Peres, JR Marks, JM Schildkraut, CS Greene, JA Doherty	12/02/2023
Menopausal hormone therapy use and risk of ovarian cancer by race: the ovarian cancer in women of African ancestry consortium. British journal of cancer	JL Petrick, CE Joslin, CE Johnson, TF Camacho, LC Peres, EV Bandera, ME Barnard, A Beeghly, TN Bethea, LF Dempsey, K Guertin, HR Harris, PG Moorman, ER Myers, HM Ochs-Balcom, W Rosenow, VW Setiawan, AH Wu, JM Schildkraut, L Rosenberg	12/01/2023
Cis- and trans-eQTL TWAS of breast and ovarian cancer identify more than 100 risk associated genes in the BCAC and OCAC consortia. bioRxiv : the preprint server for biology	ST Head, F Dezem, A Todor, J Yang, J Plummer, S Gayther, S Kar, J Schildkraut, MP Epstein	11/13/2023
The tumor multi-omic landscape of endometrial cancers developed on a germline genetic background of adiposity. medRxiv : the preprint server for health sciences	G Richenberg, A Francis, CN Owen, V Gray, T Robinson, AA Gabriel, K Lawrenson, EJ Crosbie, JM Schildkraut, JD Mckay, TR Gaunt, CL Relton, EE Vincent, SP Kar	10/10/2023
The Association between Mediated Deprivation and Ovarian Cancer Survival among African American Women. Cancers	AB Lawson, J Kim, C Johnson, KL Ratnapradipa, AJ Alberg, M Akonde, T Hastert, EV Bandera, P Terry, H Mandle, ML Cote, M Bondy, J Marks, LC Peres, J Schildkraut, ES Peters	10/04/2023
Role of neighborhood context in ovarian cancer survival disparities: current research and future directions. American journal of obstetrics and gynecology	SL Gomez, E Chirikova, V McGuire, LJ Collin, L Dempsey, PP Inamdar, K Lawson-Michod, ES Peters, LH Kushi, J Kavecansky, S Shariff-Marco, LC Peres, P Terry, EV Bandera, JM Schildkraut, JA Doherty, A Lawson	10/01/2023
Deprivation and segregation in ovarian cancer survival among African American women: a mediation analysis. Annals of epidemiology	AB Lawson, J Kim, C Johnson, T Hastert, EV Bandera, AJ Alberg, P Terry, M Akonde, H Mandle, ML Cote, M Bondy, J Marks, L Peres, KL Ratnapradipa, Y Xin, J Schildkraut, ES Peters	10/01/2023
Association of inflammation-related exposures and ovarian cancer survival in a multi-site cohort study of Black women. British journal of cancer	CE Johnson, AJ Alberg, EV Bandera, LC Peres, M Akonde, LJ Collin, ML Cote, TA Hastert, JR Hébert, ES Peters, B Qin, P Terry, AG Schwartz, M Bondy, MP Epstein, HB Mandle, JR Marks, AB Lawson, JM Schildkraut	10/01/2023
Predicted Proteome Association Studies of Breast, Prostate, Ovarian, and Endometrial Cancers Implicate Plasma Protein Regulation in Cancer Susceptibility. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	I Gregga, PDP Pharoah, SA Gayther, A Manichaikul, HK Im, SP Kar, JM Schildkraut, HE Wheeler	09/01/2023
Racial Differences in the Association of Endometriosis and Uterine Leiomyomas With the Risk of Ovarian Cancer. Obstetrics and gynecology	HR Harris, LC Peres, CE Johnson, KA Guertin, A Beeghly, EV Bandera, TN Bethea, CE Joslin, AH Wu, PG Moorman, HM Ochs-Balcom, JL Petrick, VW Setiawan, L Rosenberg, JM Schildkraut, E Myers	06/01/2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. The journal of pathology. Clinical research	M Köbel, EY Kang, A Weir, PF Rambau, CH Lee, GS Nelson, P Ghatage, NS Meagher, MJ Riggan, J Alsop, MS Anglesio, MW Beckmann, C Bisinotto, M Boisen, J Boros, AH Brand, A Brooks-Wilson, ME Carney, P Coulson, M Courtney-Brooks, KL Cushing-Haugen, C Cybulski, S Deen, MA El-Bahrawy, E Elishaev, R Erber, S Fereday, A Fischer, SA Gayther, A Barquin-Garcia, A Gentry-Maharaj, CB Gilks, H Gronwald, M Grube, PR Harnett, HR Harris, AD Hartkopf, A Hartmann, A Hein, J Hendley, BY Hernandez, Y Huang, A Jakubowska, M Jimenez-Linan, ME Jones, CJ Kennedy, T Kluz, JM Koziak, J Lesnock, J Lester, J Lubiński, TA Longacre, M Lycke, C Mateoiu, BM McCauley, V McGuire, B Ney, A Olawaiye, S Orsulic, A Osorio, L Paz-Ares, T Ramón Y Cajal, JH Rothstein, M Ruebner, MJ Schoemaker, M Shah, R Sharma, ME Sherman, YB Shvetsov, N Singh, H Steed, SJ Storr, A Talhouk, N Traficante, C Wang, AS Whittemore, M Widschwendter, LR Wilkens, SJ Winham, J Benitez, A Berchuck, DD Bowtell, FJ Candido Dos Reis, I Campbell, LS Cook, A DeFazio, JA Doherty, PA Fasching, RT Fortner, MJ García, MT Goodman, EL Goode, J Gronwald, DG Huntsman, BY Karlan, LE Kelemen, S Kommoss, ND Le, SG Martin, U Menon, F Modugno, PD Pharoah, JM Schildkraut, W Sieh, A Staebler, K Sundfeldt, AJ Swerdlow, SJ Ramus, JD Brenton	05/01/2023
The genomic landscape of familial glioma. Science advances	DJ Choi, G Armstrong, B Lozzi, P Vijayaraghavan, SE Plon, TC Wong, E Boerwinkle, DM Muzny, HC Chen, RA Gibbs, QT Ostrom, B Melin, B Deneen, ML Bondy, MN Bainbridge, CI Amos, JS Barnholtz-Sloan, JL Bernstein, EB Claus, RS Houlston, D Il'yasova, RB Jenkins, C Johansen, D Lachance, R Lai, BS Melin, RT Merrell, SH Olson, S Sadetzki, J Schildkraut, S Shete, JC Ambrose, P Arumugam, R Bevers, M Bleda, F Boardman-Pretty, CR Boustred, H Brittain, MA Brown, MJ Caulfield, GC Chan, A Giess, JN Griffin, A Hamblin, S Henderson, TJP Hubbard, R Jackson, LJ Jones, D Kasperaviciute, M Kayikci, A Kousathanas, L Lahnstein, A Lakey, SEA Leigh, IUS Leong, FJ Lopez, F Maleady-Crowe, M McEntagart, F Minneci, J Mitchell, L Moutsianas, M Mueller, N Murugaesu, AC Need, P O'Donovan, CA Odhams, C Patch, D Perez-Gil, MB Pereira, J Pullinger, T Rahim, A Rendon, T Rogers, K Savage, K Sawant, RH Scott, A Siddiq, A Sieghart, SC Smith, A Sosinsky, A Stuckey, M Tanguy, AL Taylor Tavares, ERA Thomas, SR Thompson, A Tucci, MJ Welland, E Williams, K Witkowska, SM Wood, M Zarowiecki	04/28/2023
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. Cancer	EY Kang, A Weir, NS Meagher, K Farrington, GS Nelson, P Ghatage, CH Lee, MJ Riggan, A Bolithon, G Popovic, B Leung, K Tang, N Lambie, J Millstein, J Alsop, MS Anglesio, B Ataseven, E Barlow, MW Beckmann, J Berger, C Bisinotto, H Bösmüller, J Boros, AH Brand, A Brooks-Wilson, SY Brucker, ME Carney, Y Casablanca, A Cazorla-Jiménez, PA Cohen, TP Conrads, LS Cook, P Coulson, M Courtney-Brooks, DW Cramer, P Crowe, JM Cunningham, C Cybulski, KM Darcy, MA El-Bahrawy, E Elishaev, R Erber, R Farrell, S Fereday, A Fischer, MJ García, SA Gayther, A Gentry-Maharaj, CB Gilks, M Grube, PR Harnett, SP Harrington, P Harter, A Hartmann, JL Hecht, S Heikaus, A Hein, F Heitz, J Hendley, BY Hernandez, SH Polo, S Heublein, A Hirasawa, E Høgdall, CK Høgdall, HM Horlings, DG Huntsman, T Huzarski, A Jewell, M Jimenez-Linan, ME Jones, SH Kaufmann, CJ Kennedy, D Khabele, FKF Kommoss, RFPM Kruitwagen, D Lambrechts, ND Le, M Lener, J Lester, Y Leung, A Linder, L Loverix, J Lubiński, R Madan, GL Maxwell, F Modugno, SL Neuhausen, A Olawaiye, S Olbrecht, S Orsulic, J Palacios, CL Pearce, MC Pike, CM Quinn, GR Mohan, C Rodríguez-Antona, M Ruebner, A Ryan, SG Salfinger, N Sasamoto, JM Schildkraut, MJ Schoemaker, M Shah, R Sharma, YB Shvetsov, N Singh, GS Sonke, L Steele, CJR Stewart, K Sundfeldt, AJ Swerdlow, A Talhouk, A Tan, SE Taylor, KL Terry, A Tołoczko, N Traficante, KK Van de Vijver, MA van der Aa, T Van Gorp, E Van Nieuwenhuysen, L van-Wagensveld, I Vergote, RA Vierkant, C Wang, LR Wilkens, SJ Winham, AH Wu, J Benitez, A Berchuck, FJ Candido Dos Reis, A DeFazio, PA Fasching, EL Goode, MT Goodman, J Gronwald, BY Karlan, S Kommoss, U Menon, HP Sinn, A Staebler, JD Brenton, DD Bowtell, PDP Pharoah, SJ Ramus, M Köbel	03/01/2023
Survival of epithelial ovarian cancer in Black women: a society to cell approach in the African American cancer epidemiology study (AACES). Cancer causes & control : CCC	JM Schildkraut, C Johnson, LF Dempsey, B Qin, P Terry, M Akonde, ES Peters, H Mandle, ML Cote, L Peres, P Moorman, AG Schwartz, M Epstein, J Marks, M Bondy, AB Lawson, AJ Alberg, EV Bandera	03/01/2023
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility. JAMA network open	LM Hurwitz, PM Webb, SJ Jordan, JA Doherty, HR Harris, MT Goodman, YB Shvetsov, F Modugno, KB Moysich, JM Schildkraut, A Berchuck, H Anton-Culver, A Ziogas, U Menon, SJ Ramus, AH Wu, CL Pearce, N Wentzensen, SS Tworoger, PDP Pharoah, B Trabert	02/01/2023
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study. British journal of cancer	A Weir, EY Kang, NS Meagher, GS Nelson, P Ghatage, CH Lee, MJ Riggan, A Gentry-Maharaj, A Ryan, N Singh, M Widschwendter, J Alsop, MS Anglesio, MW Beckmann, J Berger, C Bisinotto, J Boros, AH Brand, JD Brenton, A Brooks-Wilson, ME Carney, JM Cunningham, KL Cushing-Haugen, C Cybulski, E Elishaev, R Erber, S Fereday, A Fischer, L Paz-Ares, J Gayarre, BC Gilks, M Grube, PR Harnett, HR Harris, A Hartmann, A Hein, J Hendley, BY Hernandez, S Heublein, Y Huang, T Huzarski, A Jakubowska, M Jimenez-Linan, CJ Kennedy, FKF Kommoss, JM Koziak, B Kraemer, ND Le, J Lesnock, J Lester, J Lubiński, J Menkiszak, B Ney, A Olawaiye, S Orsulic, A Osorio, L Robles-Díaz, M Ruebner, M Shah, R Sharma, YB Shvetsov, H Steed, A Talhouk, SE Taylor, N Traficante, RA Vierkant, C Wang, LR Wilkens, SJ Winham, J Benitez, A Berchuck, DD Bowtell, FJ Candido Dos Reis, LS Cook, A DeFazio, JA Doherty, PA Fasching, MJ García, EL Goode, MT Goodman, J Gronwald, DG Huntsman, BY Karlan, S Kommoss, F Modugno, JM Schildkraut, HP Sinn, A Staebler, LE Kelemen, CE Ford, U Menon, PDP Pharoah, M Köbel, SJ Ramus	01/01/2023
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery. Gynecologic oncology	MT Phung, PM Webb, A DeFazio, S Fereday, AW Lee, DDL Bowtell, PA Fasching, EL Goode, MT Goodman, BY Karlan, J Lester, K Matsuo, F Modugno, JD Brenton, T Van Gorp, PDP Pharoah, JM Schildkraut, K McLean, R Meza, B Mukherjee, J Richardson, B Grout, A Chase, C McKinnon Deurloo, KL Terry, GE Hanley, MC Pike, A Berchuck, SJ Ramus, CL Pearce	01/01/2023
Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	LM Hurwitz, MK Townsend, SJ Jordan, AV Patel, LR Teras, JV Lacey, JA Doherty, HR Harris, MT Goodman, YB Shvetsov, F Modugno, KB Moysich, K Robien, A Prizment, JM Schildkraut, A Berchuck, RT Fortner, AT Chan, N Wentzensen, P Hartge, DP Sandler, KM O'Brien, H Anton-Culver, A Ziogas, U Menon, SJ Ramus, CL Pearce, AH Wu, E White, U Peters, PM Webb, SS Tworoger, B Trabert	12/20/2022
Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. Journal of the National Cancer Institute	AA DeVries, J Dennis, JP Tyrer, PC Peng, SG Coetzee, AL Reyes, JT Plummer, BD Davis, SS Chen, FS Dezem, KKH Aben, H Anton-Culver, NN Antonenkova, MW Beckmann, A Beeghly-Fadiel, A Berchuck, NV Bogdanova, N Bogdanova-Markov, JD Brenton, R Butzow, I Campbell, J Chang-Claude, G Chenevix-Trench, LS Cook, A DeFazio, JA Doherty, T Dörk, DM Eccles, AH Eliassen, PA Fasching, RT Fortner, GG Giles, EL Goode, MT Goodman, J Gronwald, N Håkansson, MAT Hildebrandt, C Huff, DG Huntsman, A Jensen, S Kar, BY Karlan, EK Khusnutdinova, LA Kiemeney, SK Kjaer, J Kupryjanczyk, M Labrie, D Lambrechts, ND Le, J Lubiński, T May, U Menon, RL Milne, F Modugno, AN Monteiro, KB Moysich, K Odunsi, H Olsson, CL Pearce, T Pejovic, SJ Ramus, E Riboli, MJ Riggan, I Romieu, DP Sandler, JM Schildkraut, VW Setiawan, W Sieh, H Song, R Sutphen, KL Terry, PJ Thompson, L Titus, SS Tworoger, E Van Nieuwenhuysen, DV Edwards, PM Webb, N Wentzensen, AS Whittemore, A Wolk, AH Wu, A Ziogas, ML Freedman, K Lawrenson, PDP Pharoah, DF Easton, SA Gayther, MR Jones	11/14/2022
Racial differences in the association of body mass index and ovarian cancer risk in the OCWAA Consortium. British journal of cancer	HM Ochs-Balcom, C Johnson, KA Guertin, B Qin, A Beeghly-Fadiel, F Camacho, TN Bethea, LF Dempsey, W Rosenow, CE Joslin, E Myers, PG Moorman, HR Harris, LC Peres, V Wendy Setiawan, AH Wu, L Rosenberg, JM Schildkraut, EV Bandera	11/01/2022
Racial disparities in epithelial ovarian cancer survival: An examination of contributing factors in the Ovarian Cancer in Women of African Ancestry consortium. International journal of cancer	HR Harris, KA Guertin, TF Camacho, CE Johnson, AH Wu, PG Moorman, E Myers, TN Bethea, EV Bandera, CE Joslin, HM Ochs-Balcom, LC Peres, WT Rosenow, VW Setiawan, A Beeghly-Fadiel, LF Dempsey, L Rosenberg, JM Schildkraut	10/15/2022
Race Differences in the Associations between Menstrual Cycle Characteristics and Epithelial Ovarian Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	R Nash, CE Johnson, HR Harris, LC Peres, CE Joslin, TN Bethea, EV Bandera, HM Ochs-Balcom, ER Myers, KA Guertin, F Camacho, A Beeghly-Fadiel, PG Moorman, VW Setiawan, L Rosenberg, JM Schildkraut, AH Wu	08/02/2022
Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian Carcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	LC Peres, C Colin-Leitzinger, S Sinha, JR Marks, JR Conejo-Garcia, AJ Alberg, EV Bandera, A Berchuck, ML Bondy, BC Christensen, ML Cote, JA Doherty, PG Moorman, ES Peters, C Moran Segura, JV Nguyen, AG Schwartz, PD Terry, CM Wilson, BL Fridley, JM Schildkraut	05/04/2022
CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis. Cancers	C Wohlmuth, V Djedovic, SK Kjaer, A Jensen, R Glasspool, P Roxburgh, A DeFazio, SE Johnatty, PM Webb, F Modugno, D Lambrechts, JM Schildkraut, A Berchuck, LCV Thomsen, L Bjorge, E Høgdall, CK Høgdall, EL Goode, SJ Winham, K Matsuo, BY Karlan, J Lester, MT Goodman, PJ Thompson, T Pejovic, MJ Riggan, K Lajkosz, A Tone, T May	04/13/2022
Reproductive Factors Do Not Influence Survival with Ovarian Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	MT Phung, A Alimujiang, A Berchuck, H Anton-Culver, JM Schildkraut, EV Bandera, J Chang-Claude, A Chase, JA Doherty, B Grout, MT Goodman, GE Hanley, AW Lee, C McKinnon Deurloo, U Menon, F Modugno, PDP Pharoah, MC Pike, J Richardson, HA Risch, W Sieh, KL Terry, PM Webb, N Wentzensen, AH Wu, CL Pearce	04/01/2022
Psychosocial factors associated with genetic testing status among African American women with ovarian cancer: Results from the African American Cancer Epidemiology Study. Cancer	CM McBride, S Pathak, CE Johnson, AJ Alberg, EV Bandera, JS Barnholtz-Sloan, ML Bondy, ML Cote, PG Moorman, LC Peres, ES Peters, AG Schwartz, PD Terry, JM Schildkraut	03/15/2022
Tumor immune cell clustering and its association with survival in African American women with ovarian cancer. PLoS computational biology	C Wilson, AC Soupir, R Thapa, J Creed, J Nguyen, CM Segura, T Gerke, JM Schildkraut, LC Peres, BL Fridley	03/01/2022
High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	KK Brieger, MT Phung, B Mukherjee, KM Bakulski, H Anton-Culver, EV Bandera, DDL Bowtell, DW Cramer, A DeFazio, JA Doherty, S Fereday, RT Fortner, A Gentry-Maharaj, EL Goode, MT Goodman, HR Harris, K Matsuo, U Menon, F Modugno, KB Moysich, B Qin, SJ Ramus, HA Risch, MA Rossing, JM Schildkraut, B Trabert, RA Vierkant, SJ Winham, N Wentzensen, AH Wu, A Ziogas, L Khoja, KR Cho, K McLean, J Richardson, B Grout, A Chase, CM Deurloo, K Odunsi, BH Nelson, JD Brenton, KL Terry, PDP Pharoah, A Berchuck, GE Hanley, PM Webb, MC Pike, CL Pearce	02/01/2022
A whole-exome case-control association study to characterize the contribution of rare coding variation to pancreatic cancer risk. HGG advances	Y Yu, K Chang, JS Chen, RJ Bohlender, J Fowler, D Zhang, M Huang, P Chang, Y Li, J Wong, H Wang, J Gu, X Wu, J Schildkraut, L Cannon-Albright, Y Ye, H Zhao, MAT Hildebrandt, JB Permuth, D Li, P Scheet, CD Huff	01/13/2022
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association. Gynecologic oncology	L Khoja, RP Weber, PM Webb, SJ Jordan, A Muthukumar, J Chang-Claude, RT Fortner, A Jensen, SK Kjaer, H Risch, JA Doherty, HR Harris, MT Goodman, F Modugno, K Moysich, A Berchuck, JM Schildkraut, D Cramer, KL Terry, H Anton-Culver, A Ziogas, MT Phung, GE Hanley, AH Wu, B Mukherjee, K McLean, K Cho, MC Pike, CL Pearce, AW Lee	01/01/2022
Pleiotropic MLLT10 variation confers risk of meningioma and estrogen-mediated cancers. Neuro-oncology advances	KM Walsh, C Zhang, L Calvocoressi, HM Hansen, A Berchuck, JM Schildkraut, ML Bondy, M Wrensch, JL Wiemels, EB Claus	01/01/2022
Increasing Area Deprivation Index negatively impacts ovarian cancer survival. Cancer epidemiology	DH Hufnagel, D Khabele, FE Yull, PC Hull, J Schildkraut, MA Crispens, A Beeghly-Fadiel	10/01/2021
Genital Powder Use and Risk of Epithelial Ovarian Cancer in the Ovarian Cancer in Women of African Ancestry Consortium. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	CP Davis, EV Bandera, TN Bethea, F Camacho, CE Joslin, AH Wu, A Beeghly-Fadiel, PG Moorman, ER Myers, HM Ochs-Balcom, LC Peres, WT Rosenow, VW Setiawan, L Rosenberg, JM Schildkraut, HR Harris	09/01/2021
Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	MCJ Quinn, K McCue, W Shi, SE Johnatty, J Beesley, A Civitarese, TA O'Mara, DM Glubb, JP Tyrer, SM Armasu, JS Ong, P Gharahkhani, Y Lu, B Gao, AM Patch, PA Fasching, MW Beckmann, D Lambrechts, I Vergote, DR Velez Edwards, A Beeghly-Fadiel, J Benitez, MJ Garcia, MT Goodman, T Dörk, M Dürst, F Modugno, K Moysich, A du Bois, J Pfisterer, K Bauman, BY Karlan, J Lester, JM Cunningham, MC Larson, BM McCauley, SK Kjaer, A Jensen, CK Hogdall, E Hogdall, JM Schildkraut, MJ Riggan, A Berchuck, DW Cramer, KL Terry, L Bjorge, PM Webb, M Friedlander, T Pejovic, M Moffitt, R Glasspool, T May, GEV Ene, DG Huntsman, M Woo, ME Carney, S Hinsley, F Heitz, S Fereday, CJ Kennedy, SL Edwards, SJ Winham, A deFazio, PDP Pharoah, EL Goode, S MacGregor, G Chenevix-Trench	09/01/2021
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer. HGG advances	SP Kar, DPC Considine, JP Tyrer, JT Plummer, S Chen, FS Dezem, AN Barbeira, PS Rajagopal, WT Rosenow, F Moreno, C Bodelon, J Chang-Claude, G Chenevix-Trench, A deFazio, T Dörk, AB Ekici, A Ewing, G Fountzilas, EL Goode, M Hartman, F Heitz, P Hillemanns, E Høgdall, CK Høgdall, T Huzarski, A Jensen, BY Karlan, E Khusnutdinova, LA Kiemeney, SK Kjaer, R Klapdor, M Köbel, J Li, C Liebrich, T May, H Olsson, JB Permuth, P Peterlongo, P Radice, SJ Ramus, MJ Riggan, HA Risch, E Saloustros, J Simard, LM Szafron, L Titus, CL Thompson, RA Vierkant, SJ Winham, W Zheng, JA Doherty, A Berchuck, K Lawrenson, HK Im, AW Manichaikul, PDP Pharoah, SA Gayther, JM Schildkraut	07/08/2021
Challenges and Opportunities in the Statistical Analysis of Multiplex Immunofluorescence Data. Cancers	CM Wilson, OE Ospina, MK Townsend, J Nguyen, C Moran Segura, JM Schildkraut, SS Tworoger, LC Peres, BL Fridley	06/17/2021
First- and second-degree family history of ovarian and breast cancer in relation to risk of invasive ovarian cancer in African American and white women. International journal of cancer	TN Bethea, HM Ochs-Balcom, EV Bandera, A Beeghly-Fadiel, F Camacho, D Chyn, EK Cloyd, HR Harris, CE Joslin, E Myers, PG Moorman, LC Peres, W Rosenow, VW Setiawan, AH Wu, L Rosenberg, JM Schildkraut	06/15/2021
Racial Differences in Population Attributable Risk for Epithelial Ovarian Cancer in the OCWAA Consortium. Journal of the National Cancer Institute	LC Peres, TN Bethea, TF Camacho, EV Bandera, A Beeghly-Fadiel, DL Chyn, HR Harris, CE Joslin, PG Moorman, E Myers, HM Ochs-Balcom, W Rosenow, VW Setiawan, AH Wu, L Rosenberg, JM Schildkraut	06/01/2021
Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	MT Phung, AW Lee, AH Wu, A Berchuck, KR Cho, DW Cramer, JA Doherty, MT Goodman, GE Hanley, HR Harris, K McLean, F Modugno, KB Moysich, B Mukherjee, JM Schildkraut, KL Terry, LJ Titus, SJ Jordan, PM Webb, MC Pike, CL Pearce	05/01/2021
Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer. Journal of medical genetics	H Song, EM Dicks, J Tyrer, M Intermaggio, G Chenevix-Trench, DD Bowtell, N Traficante, A Group, J Brenton, T Goranova, K Hosking, A Piskorz, E van Oudenhove, J Doherty, HR Harris, MA Rossing, M Duerst, T Dork, NV Bogdanova, F Modugno, K Moysich, K Odunsi, R Ness, BY Karlan, J Lester, A Jensen, S Krüger Kjaer, E Høgdall, IG Campbell, C Lázaro, MA Pujara, J Cunningham, R Vierkant, SJ Winham, M Hildebrandt, C Huff, D Li, X Wu, Y Yu, JB Permuth, DA Levine, JM Schildkraut, MJ Riggan, A Berchuck, PM Webb, OS Group, C Cybulski, J Gronwald, A Jakubowska, J Lubinski, J Alsop, P Harrington, I Chan, U Menon, CL Pearce, AH Wu, A de Fazio, CJ Kennedy, E Goode, S Ramus, S Gayther, P Pharoah	05/01/2021
Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies. Journal of the National Cancer Institute	AW Lee, S Rosenzweig, A Wiensch, SJ Ramus, U Menon, A Gentry-Maharaj, A Ziogas, H Anton-Culver, AS Whittemore, W Sieh, JH Rothstein, V McGuire, N Wentzensen, EV Bandera, B Qin, KL Terry, DW Cramer, L Titus, JM Schildkraut, A Berchuck, EL Goode, SK Kjaer, A Jensen, SJ Jordan, RB Ness, F Modugno, K Moysich, PJ Thompson, MT Goodman, ME Carney, J Chang-Claude, MA Rossing, HR Harris, JA Doherty, HA Risch, L Khoja, A Alimujiang, MT Phung, K Brieger, B Mukherjee, PDP Pharoah, AH Wu, MC Pike, PM Webb, CL Pearce	03/01/2021
Genetically predicted circulating protein biomarkers and ovarian cancer risk. Gynecologic oncology	DPC Considine, G Jia, X Shu, JM Schildkraut, PDP Pharoah, W Zheng, SP Kar	02/01/2021
Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies. European journal of epidemiology	F Modugno, Z Fu, SJ Jordan, A Group, J Chang-Claude, RT Fortner, MT Goodman, KB Moysich, JM Schildkraut, A Berchuck, EV Bandera, B Qin, R Sutphen, JR McLaughlin, U Menon, SJ Ramus, SA Gayther, A Gentry-Maharaj, C Karpinskyj, CL Pearce, AH Wu, HA Risch, PM Webb	11/01/2020
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE). Clinical cancer research : an official journal of the American Association for Cancer Research	A Talhouk, J George, C Wang, T Budden, TZ Tan, DS Chiu, S Kommoss, HS Leong, S Chen, MP Intermaggio, B Gilks, TM Nazeran, M Volchek, W Elatre, RC Bentley, J Senz, A Lum, V Chow, H Sudderuddin, R Mackenzie, SCY Leong, G Liu, D Johnson, B Chen, A Group, J Alsop, SN Banerjee, S Behrens, C Bodelon, AH Brand, L Brinton, ME Carney, YE Chiew, KL Cushing-Haugen, C Cybulski, D Ennis, S Fereday, RT Fortner, J García-Donas, A Gentry-Maharaj, R Glasspool, T Goranova, CS Greene, P Haluska, HR Harris, J Hendley, BY Hernandez, E Herpel, M Jimenez-Linan, C Karpinskyj, SH Kaufmann, GL Keeney, CJ Kennedy, M Köbel, JM Koziak, MC Larson, J Lester, LA Lewsley, J Lissowska, J Lubiński, H Luk, G Macintyre, S Mahner, IA McNeish, J Menkiszak, N Nevins, A Osorio, O Oszurek, J Palacios, S Hinsley, CL Pearce, MC Pike, AM Piskorz, I Ray-Coquard, V Rhenius, C Rodriguez-Antona, R Sharma, ME Sherman, D De Silva, N Singh, P Sinn, D Slamon, H Song, H Steed, EA Stronach, PJ Thompson, A Tołoczko, B Trabert, N Traficante, CC Tseng, M Widschwendter, LR Wilkens, SJ Winham, B Winterhoff, A Beeghly-Fadiel, J Benitez, A Berchuck, JD Brenton, R Brown, J Chang-Claude, G Chenevix-Trench, A deFazio, PA Fasching, MJ García, SA Gayther, MT Goodman, J Gronwald, MJ Henderson, BY Karlan, LE Kelemen, U Menon, S Orsulic, PDP Pharoah, N Wentzensen, AH Wu, JM Schildkraut, MA Rossing, GE Konecny, DG Huntsman, RY Huang, EL Goode, SJ Ramus, JA Doherty, DD Bowtell, MS Anglesio	10/15/2020
Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nature communications	YD Zhang, AN Hurson, H Zhang, PP Choudhury, DF Easton, RL Milne, J Simard, P Hall, K Michailidou, J Dennis, MK Schmidt, J Chang-Claude, P Gharahkhani, D Whiteman, PT Campbell, M Hoffmeister, M Jenkins, U Peters, L Hsu, SB Gruber, G Casey, SL Schmit, TA O'Mara, AB Spurdle, DJ Thompson, I Tomlinson, I De Vivo, MT Landi, MH Law, MM Iles, F Demenais, R Kumar, S MacGregor, DT Bishop, SV Ward, ML Bondy, R Houlston, JK Wiencke, B Melin, J Barnholtz-Sloan, B Kinnersley, MR Wrensch, CI Amos, RJ Hung, P Brennan, J McKay, NE Caporaso, SI Berndt, BM Birmann, NJ Camp, P Kraft, N Rothman, SL Slager, A Berchuck, PDP Pharoah, TA Sellers, SA Gayther, CL Pearce, EL Goode, JM Schildkraut, KB Moysich, LT Amundadottir, EJ Jacobs, AP Klein, GM Petersen, HA Risch, RZ Stolzenberg-Solomon, BM Wolpin, D Li, RA Eeles, CA Haiman, Z Kote-Jarai, FR Schumacher, AA Al Olama, MP Purdue, G Scelo, MD Dalgaard, MH Greene, T Grotmol, PA Kanetsky, KA McGlynn, KL Nathanson, C Turnbull, F Wiklund, SJ Chanock, N Chatterjee, M Garcia-Closas	07/03/2020
Invited Commentary: Relationship Between Ovulation and Markers of Systemic Inflammation Versus Markers of Localized Inflammation. American journal of epidemiology	JM Schildkraut	07/01/2020
Cardiometabolic comorbidities and epithelial ovarian cancer risk among African-American women in the African-American Cancer Epidemiology Study (AACES). Gynecologic oncology	JN Staples, LC Peres, F Camacho, AJ Alberg, EV Bandera, J Barnholtz-Sloan, ML Bondy, ML Cote, E Funkhouser, PG Moorman, ES Peters, AG Schwartz, PD Terry, JM Schildkraut	07/01/2020
Association Between Breastfeeding and Ovarian Cancer Risk. JAMA oncology	A Babic, N Sasamoto, BA Rosner, SS Tworoger, SJ Jordan, HA Risch, HR Harris, MA Rossing, JA Doherty, RT Fortner, J Chang-Claude, MT Goodman, PJ Thompson, KB Moysich, RB Ness, SK Kjaer, A Jensen, JM Schildkraut, LJ Titus, DW Cramer, EV Bandera, B Qin, W Sieh, V McGuire, R Sutphen, CL Pearce, AH Wu, M Pike, PM Webb, F Modugno, KL Terry	06/01/2020
Racial/ethnic disparities in ovarian cancer research. Advances in cancer research	LC Peres, JM Schildkraut	01/01/2020